C14ORF43 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.606400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.137600E-01
Normal-vs-Stage2
4.724800E-01
Normal-vs-Stage3
1.565800E-01
Normal-vs-Stage4
5.155400E-01
Stage1-vs-Stage2
5.662000E-01
Stage1-vs-Stage3
1.201770E-01
Stage1-vs-Stage4
3.107800E-01
Stage2-vs-Stage3
6.548300E-02
Stage2-vs-Stage4
5.120800E-01
Stage3-vs-Stage4
1.237810E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.559400E-01
Normal-vs-AfricanAmerican
2.873800E-01
Normal-vs-Asian
1.317570E-01
Caucasian-vs-AfricanAmerican
9.998200E-01
Caucasian-vs-Asian
5.380800E-01
AfricanAmerican-vs-Asian
7.545800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.780800E-01
Normal-vs-Female
4.409600E-01
Male-vs-Female
3.715200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.554000E-01
Normal-vs-Age(41-60Yrs)
5.710800E-01
Normal-vs-Age(61-80Yrs)
4.180800E-01
Normal-vs-Age(81-100Yrs)
3.835200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.597600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.565400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.442630E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.782530E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.161700E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.015400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.419400E-01
Normal-vs-Daily Drinker
4.184800E-01
Normal-vs-Weekly Drinker
3.993000E-01
Normal-vs-Occasional Drinker
4.908600E-01
Normal-vs-Social Drinker
4.857200E-01
Non Drinker-vs-Daily Drinker
7.455400E-01
Non Drinker-vs-Weekly Drinker
5.854800E-01
Non Drinker-vs-Occasional Drinker
6.147000E-01
Non Drinker-vs-Social Drinker
6.429400E-01
Daily Drinker-vs-Weekly Drinker
8.086000E-01
Daily Drinker-vs-Occasional Drinker
4.630800E-01
Daily Drinker-vs-Social Drinker
4.779400E-01
Weekly Drinker-vs-Occasional Drinker
3.816200E-01
Weekly Drinker-vs-Social Drinker
3.732000E-01
Occasional Drinker-vs-Social Drinker
9.699000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.740200E-02
Normal-vs-Grade 2
8.221900E-03
Normal-vs-Grade 3
8.880700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.829160E-01
Grade 1-vs-Grade 3
9.348100E-02
Grade 1-vs-Grade 4
6.740200E-02
Grade 2-vs-Grade 3
4.286800E-01
Grade 2-vs-Grade 4
8.221900E-03
Grade 3-vs-Grade 4
8.880700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.141200E-01
Normal-vs-NonDiabetic
4.674400E-01
Diabetic-vs-NonDiabetic
2.633200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.148000E-01
Normal-vs-NoPancreatitis
4.581600E-01
Pancreatitis-vs-NoPancreatitis
5.543600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.231000E-01
Normal-vs-N1
4.791000E-01
N0-vs-N1
2.094800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.940400E-01
Normal-vs-TP53-NonMutant
4.128400E-01
TP53-Mutant-vs-TP53-NonMutant
1.853410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
